Josef Eiblmaier

Head of Research, Discovery and Pre-Clinical, PharmaLex, a Cencora company

The beauty of heterogeneity versus the need for standardization: Enabling trusted data consumption in a multi-source, multi-ownership data landscape

Josef showcases how data virtualization helps to integrate heterogeneous drug discovery data from multiple sources to make them usable by data-driven predictive models. He presents a centralized data access platform capable of integrating new data sources.

bio

Talks you might be also interested in

Timur-Madzhidov_intro_1920x1080

Timur Madzhidov

Elsevier

Unlocking the power of data from disparate sources – Elsevier’s journey toward accurate reaction outcome predictions.

Watch Now
Thrasyvoulos-Karydis_intro_1920x1080

Thrasyvoulos Karydis

Deepcure

Is AI in Drug Discovery trapped in the data of the past?

Watch now
Becky-Upton_intro_1920x1080

Becky Upton

Pistoia Alliance

Ontologies in Pharma: The landscape, pre-competitive development, and use-cases

Watch now